Recovery
Wolverine
Peptide blend / Injection
Recovery & performance
BPC-157
Peptide protocol supporting tissue repair and recovery.
Medical guidance
Clinical review required
This listing is educational only. It is not offered for ordering, and no supply can be reserved here.
Availability and treatment are not guaranteed.
vidameds
Compounded medications are not FDA-approved.
Understanding BPC-157
Know the treatment.
Ask better questions.
BPC-157 is an experimental peptide discussed in recovery research. It is not an FDA-approved medicine, and well-designed human studies are limited.
How it works
Laboratory and animal studies explore tissue-related pathways. Those findings do not demonstrate injury-healing benefits in people.
Safety & suitability
Human safety, effective dosing, and long-term effects are not established. Potential immune reactions and peptide impurities are concerns. Athletes should also check anti-doping restrictions.
Bring to your care conversation
- What established rehabilitation options address the cause of my injury?
- What is the exact formulation, and which approved alternatives should I consider?
- What side effects, interactions, and follow-up should we discuss before a decision?
Research, in perspective
What the evidence says.
Promising biology is not proof of injury healing.
Most BPC-157 research involves laboratory or animal models. A two-person human IV pilot cannot establish healing benefit or general safety.
FDA flags potential immune reactions, peptide impurities, and insufficient safety information. Well-designed human evidence establishing injury-recovery benefits is lacking.
Read the sourcesEvidence at a glance
What has been studied
Preclinical tissue research and very small exploratory human work.
What remains unknown
Reliable human efficacy, long-term safety, and route-specific risks.
What this means for you
Evidence must match the ingredient, formulation, and condition. A biological mechanism is not a guaranteed clinical result.
01
Experimental tissue-signaling research
02
Mostly laboratory and animal observations
03
Human healing benefits and long-term safety unestablished
Sources & further reading
- 01FDA: Compounding substances with potential significant safety risks
- 02BPC-157: Two-person intravenous pilot (2025)
Research context is educational and does not confirm the safety, effectiveness, or availability of the pictured product.
The Vida Meds difference
Connected care.
Personal at every step.
A nationwide provider network. Direct pharmacy pricing. A team you can reach.
200+
Licensed providers
A nationwide network of licensed clinicians.
50 states
Nationwide care
Our provider network spans all 50 states.
Direct pharmacy
Pricing
Direct Pharmacy Pricing for your treatment.
Overnight
ColdChain Shipping
Temperature-controlled shipping for medications that require it.
24-hour
Customer support
Support for your questions, around the clock.
Direct access
Patient portal
Connect with your provider and dedicated care team.
Treatment eligibility, medication availability, and shipping arrangements depend on clinical review and the prescribed medication. Customer support is not emergency care; call 911 for a medical emergency.
Beyond the medication
Make room for recovery.
Recovery is part of progress. Explore the role of rest, rehabilitation, and medical evaluation—and take a clear-eyed look at emerging peptide research.
Explore recovery & performance
